ESMO 2025: AI biomarkers move from promise to practice

At this year’s ESMO Congress in Berlin, one message was clear: AI-based biomarkers are exiting the lab and entering real clinical decisions. From digital pathology to CT radiomics and multi-omics, teams showed practical ways to read response earlier and adapt treatment more precisely.




https://nexomic.com/blog/esmo-....2025-ai-biomarkers-m